Nuo Therapeutics, Inc.

AURX · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$284$929$2,051$148
Short-Term Investments$0$0$0$0
Receivables$248$251$92$0
Inventory$150$210$240$0
Other Curr. Assets$159$174$251$51
Total Curr. Assets$842$1,563$2,635$150
Property Plant & Equip (Net)$348$314$412$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$348$314$412$0
Other Assets$0$0$0$0
Total Assets$1,190$1,878$3,047$150
Liabilities
Payables$219$395$398$527
Short-Term Debt$67$91$159$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$292$189$44$147
Total Curr. Liab.$578$675$600$672
LT Debt$97$164$256$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$97$164$256$0
Other Liabilities$0$0$0$0
Cap. Leases$164$256$335$0
Total Liabilities$676$839$856$672
Equity
Pref Stock$0$0$0$0
Common Stock$5$4$4$3
Retained Earnings-$32,260-$29,936-$26,765-$23,521
AOCI$0$0$0$0
Other Equity$32,769$30,971$28,952$24,382
Total Equity$514$1,039$2,191-$523
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,190$1,878$3,047$150
Net Debt-$120-$673-$1,637-$148
Nuo Therapeutics, Inc. (AURX) Financial Statements & Key Stats | AlphaPilot